Clinical Trial Update: Use of Blinded Tapering for Hypnotic Discontinuation [Phase 3]

View source ↗

Summary

The trial update shows a Phase 3 study on blinded tapering for discontinuing hypnotics in people with insomnia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Snippet

Sponsor: National Jewish Health | Conditions: Hypnotic Dependence Among Those With Insomnia | Phase 3 | Status: ACTIVE_NOT_RECRUITING